BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25302414)

  • 1. Henoch-Schonlein purpura with lupus-like nephritis: an uncommon occurrence.
    Abdwani R; Abdalla E; El-Naggari M; Al Riyami M
    Int J Rheum Dis; 2017 Nov; 20(11):1853-1855. PubMed ID: 25302414
    [No Abstract]   [Full Text] [Related]  

  • 2. IgA vasculitis (formerly Henoch-Schönlein purpura) in an adult with systemic lupus erythematosus.
    Bernardino V; Mendes-Bastos P; Rodrigues A; Riso N
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26354836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Henoch-Schönlein purpura in children.
    Trnka P
    J Paediatr Child Health; 2013 Dec; 49(12):995-1003. PubMed ID: 24134307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful multitarget therapy using prednisolone, mizoribine and tacrolimus for Henoch-Schönlein purpura nephritis in children.
    Ichiyama S; Matayoshi T; Kaneko T; Shimizu A; Osada SI; Watanabe A; Kanzaki A; Mitsui K; Tsuruoka S; Iwakiri K; Kawana S; Saeki H
    J Dermatol; 2017 Apr; 44(4):e56-e57. PubMed ID: 27667139
    [No Abstract]   [Full Text] [Related]  

  • 5. Unusual presentation of systemic lupus erythematosus.
    Mahesh E; Madhyastha PR; Varma V; Gurudev KC; Gireesh MS; Bande SR
    Saudi J Kidney Dis Transpl; 2017; 28(3):653-656. PubMed ID: 28540909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus and lupus nephritis.
    Koutsokeras T; Healy T
    Nat Rev Drug Discov; 2014 Mar; 13(3):173-4. PubMed ID: 24525782
    [No Abstract]   [Full Text] [Related]  

  • 7. [Multicenter investigation of diagnosis and treatment of Henoch-Schonlein purpura nephritis in childhood].
    Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Disease
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):881-7. PubMed ID: 24495756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local leukocyte proliferation as a target for cyclophosphamide in the treatment of Henoch-Schönlein purpura nephritis grade VI.
    Kaneko M; Ikezumi Y; Yamada T; Hasegawa H; Kaneko U; Saitoh A
    Nephrology (Carlton); 2016 Jan; 21(1):68-71. PubMed ID: 26693846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE.
    das Chagas Medeiros MM; Bezerra MC; Braga FN; da Justa Feijão MR; Gois AC; Rebouças VC; de Carvalho TM; Carvalho LN; Ribeiro ÁM
    Lupus; 2016 Apr; 25(4):355-63. PubMed ID: 26405022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear antibody in Henoch-Schönlein purpura.
    Saulsbury FT
    Am J Med Sci; 1986 Mar; 291(3):180-2. PubMed ID: 3513566
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of nephritis in Henoch-Schönlein purpura.
    Szemenyei C; Hahn D
    J Paediatr Child Health; 2015 Feb; 51(2):236-9. PubMed ID: 25677491
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systemic lupus erythematosus].
    Kneitz C; Goebeler M; Tony HP
    Internist (Berl); 2003 Dec; 44(12):1557-71; quiz 1572-3. PubMed ID: 15132164
    [No Abstract]   [Full Text] [Related]  

  • 13. IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.
    Hall RP; Lawley TJ; Heck JA; Katz SI
    Clin Exp Immunol; 1980 Jun; 40(3):431-7. PubMed ID: 7418261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.
    Delbet JD; Hogan J; Aoun B; Stoica I; Salomon R; Decramer S; Brocheriou I; Deschênes G; Ulinski T
    Pediatr Nephrol; 2017 Jul; 32(7):1193-1199. PubMed ID: 28204946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic lupus erythematosus in children and adolescents].
    Sallmann S; Fiebig B; Hedrich CM; Heubner G; Gahr M
    Z Rheumatol; 2006 Nov; 65(7):576-8, 580-2, 584-5. PubMed ID: 17072573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe Henoch-Schönlein nephritis: justifying more immunosuppression.
    Altugan FS; Ozen S; Aktay-Ayaz N; Güçer S; Topaloğlu R; Düzova A; Ozaltin F; Beşbaş N
    Turk J Pediatr; 2009; 51(6):551-5. PubMed ID: 20196388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study.
    Calvo-Río V; Loricera J; Martín L; Ortiz-Sanjuán F; Alvarez L; González-Vela MC; González-Lamuño D; Mata C; Gortázar P; Rueda-Gotor J; Arias M; Peiró E; Martínez-Taboada VM; González-Gay MA; Blanco R
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S45-51. PubMed ID: 23663681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA nephropathy and Henoch-Schönlein purpura nephritis.
    Sanders JT; Wyatt RJ
    Curr Opin Pediatr; 2008 Apr; 20(2):163-70. PubMed ID: 18332712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Henoch-Schönlein Purpura: A Literature Review.
    Hetland LE; Susrud KS; Lindahl KH; Bygum A
    Acta Derm Venereol; 2017 Nov; 97(10):1160-1166. PubMed ID: 28654132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of immunofluorescence in the diagnosis of glomerulonephritis not related to systemic diseases.
    Morel-Maroger L; Adam C; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():81-110. PubMed ID: 4143636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.